Hybrid eventIn-person & virtual
March 15–17, 2027Singapore · Village Hotel Changi
Session Track · IOC 2027

Artificial Vision and Retinal Implants at IOC 2027

Part of the IOC 2027 scientific programme · Village Hotel Changi, Singapore · March 15–17, 2027

About the Artificial Vision and Retinal Implants Session

Advanced prosthetic systems are redefining possibilities in vision restoration for patients with profound sight loss. Artificial vision and retinal implants explore the development and clinical use of visual prostheses designed to stimulate viable retinal or cortical structures. These systems often integrate external image capture with implanted microelectrode arrays that relay signals to the brain, enabling perception of light, motion, and basic shapes. Though current devices offer limited resolution, they can significantly improve environmental awareness and mobility. Ongoing research in optogenetic stimulation, wireless subretinal arrays, and cortical implants aims to enhance image clarity and user experience. Functional success also depends on post-implant rehabilitation and the brain's ability to adapt to artificial input. As the field progresses, collaboration between neuroscientists, engineers, and ophthalmologists is key to refining these technologies and expanding their clinical impact for patients with irreversible retinal conditions.

Topics Covered in Artificial Vision and Retinal Implants

Topic 01

Epiretinal Implants

Topic 02

Wireless Subretinal Arrays

Topic 03

Cortical Visual Prostheses

Topic 04

Optogenetic Stimulation

Topic 05

Outer Retinal Degeneration

Topic 06

Prosthetic Vision Rehabilitation

Related Scientific Sessions at IOC 2027

Why Attend the Artificial Vision and Retinal Implants Conference 2027

Earn CPD Credit

Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.

Present Your Research

Oral and poster slots for original Artificial Vision and Retinal Implants work, reviewed by the scientific committee.

Network Globally

Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.

Publish & Get Indexed

Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.

Learn from Keynotes

Plenary lectures from leading voices shaping Artificial Vision and Retinal Implants research and practice.

Hybrid Flexibility

Attend in person in Singapore or join virtually — same programme, same certificate.

Join IOC 2027 for the Artificial Vision and Retinal Implants track

Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.

Artificial Vision and Retinal Implants Conference 2027 — FAQs

What is the Artificial Vision and Retinal Implants track at IOC 2027?

The Artificial Vision and Retinal Implants track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Artificial Vision and Retinal Implants. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.

Who should attend the Artificial Vision and Retinal Implants sessions?

Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Artificial Vision and Retinal Implants are all welcome — whether presenting or attending.

Can I present my research in the Artificial Vision and Retinal Implants track?

Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.

Is virtual attendance available for Artificial Vision and Retinal Implants sessions?

Yes. IOC 2027 is a hybrid conference — attend the Artificial Vision and Retinal Implants track in person in Singapore or join live online, with on-demand access afterward.

Join the IOC 2027 delegation

Singapore · March 15–17, 2027· Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.

Chat with us